REPARE THERAPEUTICS INC's ticker is RPTX and the CUSIP is 760273102. A total of 70 filers reported holding REPARE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 0.24 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,513,710 | +91473.5% | 458,700 | +30.7% | 0.00% | 0.0% |
| Q1 2024 | $1,653 | -36.4% | 351,000 | -1.4% | 0.00% | -25.0% |
| Q4 2023 | $2,598 | +40.7% | 355,826 | +132.7% | 0.00% | +33.3% |
| Q3 2023 | $1,847 | +19.6% | 152,900 | +4.8% | 0.00% | +50.0% |
| Q2 2023 | $1,544 | -31.8% | 145,900 | -36.6% | 0.00% | -33.3% |
| Q1 2023 | $2,263 | -5.9% | 230,000 | +40.8% | 0.00% | 0.0% |
| Q4 2022 | $2,404 | -99.9% | 163,400 | +20.9% | 0.00% | +50.0% |
| Q3 2022 | $1,639,000 | -35.2% | 135,121 | -25.3% | 0.00% | -33.3% |
| Q2 2022 | $2,531,000 | +101.7% | 180,900 | +105.3% | 0.00% | +200.0% |
| Q1 2022 | $1,255,000 | -31.4% | 88,100 | +1.6% | 0.00% | -50.0% |
| Q4 2021 | $1,829,000 | +314.7% | 86,700 | +416.1% | 0.00% | +100.0% |
| Q3 2021 | $441,000 | -30.7% | 16,800 | -17.6% | 0.00% | 0.0% |
| Q2 2021 | $636,000 | – | 20,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CHI Advisors LLC | 2,539,644 | $79,186,000 | 18.42% |
| MPM ASSET MANAGEMENT LLC | 2,271,177 | $70,815,000 | 13.16% |
| MPM BioImpact LLC | 1,676,087 | $52,260,000 | 8.58% |
| BVF INC/IL | 3,722,398 | $116,064,000 | 4.35% |
| GREAT POINT PARTNERS LLC | 436,089 | $13,597,000 | 2.85% |
| Redmile Group, LLC | 2,624,396 | $81,829,000 | 1.21% |
| Orbimed Advisors | 3,426,325 | $106,833,000 | 1.08% |
| SECTORAL ASSET MANAGEMENT INC | 412,150 | $12,851,000 | 1.04% |
| Logos Global Management LP | 330,000 | $10,289,000 | 0.86% |
| CLOUGH CAPITAL PARTNERS L P | 348,279 | $10,859,000 | 0.59% |